Accolade (ACCD) Financials: Revenue & Earnings
$575.59M
Market Cap
-5.28
P/E
19.50
Forward P/E
57
Score
AI Analysis
SnapshotAccolade is a growth-led story right now — Growth 86/100 is the pillar doing the heavy lifting (overall 57/100) in Medical - Healthcare Information Services. Under the hood: revenue compounding ~38% annually over recent years. Street targets still imply ~99% upside. Competition and a weaker print than the market expects are the fastest ways this setup breaks.
Price History
Financial Summary
Accolade, Inc. (ACCD) last printed $7.02. Equity value is $575.59M. Trailing earnings multiple -5.28. The revenue row is reported history. Targets and ratings are on the forecast page.
Financials
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| $76.83M | $94.81M | $132.51M | $170.36M | $310.02M | $363.14M | $414.29M |
About
Accolade, Inc., along with its subsidiaries, specializes in providing innovative, technology-driven solutions across the United States. These solutions are designed to empower individuals to better understand, navigate, and ultimately leverage both the complex healthcare system and their available workplace benefits. At the core of its offering is a robust cloud-based platform that delivers comprehensive, multimodal support. This assistance comes from a dedicated team of health assistants and clinical professionals, including registered nurses, physician medical directors, and specialists in behavioral health. Furthermore, Accolade extends its services to include valuable second opinion consultations and crucial decision-making support for healthcare matters. The company primarily serves employers who aim to furnish their employees and their families with a unified, easily accessible resource for all their health, medical care, and benefits-related inquiries. Established in 2007, Accolade, Inc. maintains its corporate headquarters in Plymouth Meeting, Pennsylvania.